Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
38 hedge funds and large institutions have $18.7M invested in Lumos Pharma, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 37 → 38 (+1)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
31% less capital invested
Capital invested by funds: $27.3M → $18.7M (-$8.53M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$2.99M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
+$87.1K |
| 3 |
PAM
PVG Asset Management
Golden,
Colorado
|
+$85.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$43K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$11.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPC
Lion Point Capital
New York
|
-$2.99M |
| 2 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$1.26M |
| 3 |
Millennium Management
New York
|
-$146K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$113K |
| 5 |
Renaissance Technologies
New York
|
-$78.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $8K | +$790 | +94 | +8% |
|
|
WFA
27
West Financial Advisors
Des Moines,
Iowa
| $5K | – | – | – |
|
28
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $3K | – | – | – |
|
|
ST
29
Sphinx Trading
Chicago,
Illinois
| $2K | – | – | – |
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$34 | +4 | +2% |
|
|
CFGS
31
Concourse Financial Group Securities
Birmingham,
Alabama
| $1K | – | – | – |
|
32
Group One Trading
Chicago,
Illinois
| $1K | – | – | – |
|
33
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $1K | – | – | – |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| $1K | +$714 | +85 | +8,500% |
|
|
CSB
35
City State Bank
Norwalk,
Iowa
| $1K | +$933 | +111 | New |
|
|
36
Millennium Management
New York
| – | -$146K | -15,348 | Closed |
|
|
37
Citadel Advisors
Miami,
Florida
| – | -$113K | -11,869 | Closed |
|
38
Northern Trust
Chicago,
Illinois
| – | -$10K | -1,008 | Closed |
|
39
Bank of America
Charlotte,
North Carolina
| – | +$84 | +10 | New |
|
LUMO Hedge Fund Activity: Q4 2021 in Review
38 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q4 2021, worth a combined $18.7M — down 31% from $27.3M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new LUMO positions and 5 closed out — a net gain of 1 holder — while 7 added to existing stakes and 9 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $2.99M. The largest seller was Lion Point Capital, cutting an estimated $2.99M.
- 38 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q4 2021, up from 37 in Q3 2021.
- Funds reported $18.7M of Lumos Pharma, Inc. Common Stock stock for Q4 2021, down 31% quarter-over-quarter.
- 6 funds opened new Lumos Pharma, Inc. Common Stock positions in Q4 2021 and 5 closed out, a net change of +1 holder.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q4 2021 was Goldman Sachs, an estimated $2.99M added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q4 2021 was Lion Point Capital, an estimated $2.99M sold.
Based on aggregated 13F filings for Q4 2021.